Expand DYN Menu
DYN MENU

DYN Latest Press Releases

-- November 12, 2024 --

Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update Globe Newswire 7:30 AM

-- November 7, 2024 --

Dyne Therapeutics to Present at Upcoming Investor Conferences Globe Newswire 4:15 PM

-- November 2, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN PRNewswire 11:00 AM

-- October 25, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN PRNewswire 5:52 PM

-- October 9, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN PRNewswire 5:41 PM
Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE Platform to Address Underlying Causes of Neuromuscular Diseases Globe Newswire 7:30 AM

-- October 3, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN PRNewswire 10:30 AM

-- September 25, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN PRNewswire 3:26 PM

-- September 23, 2024 --

Dyne Therapeutics to Present at Chardan's 8th Annual Genetic Medicines Conference Globe Newswire 8:56 AM

-- September 20, 2024 --

Bragar Eagel & Squire, P.C. Is Investigating Dyne, Napco, and Franklin and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM

-- September 17, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN PRNewswire 6:35 PM
DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm! Globe Newswire 4:00 PM

-- September 16, 2024 --

DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm! Business Wire 4:00 PM

-- September 15, 2024 --

DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm! PRNewswire 4:00 PM

-- September 11, 2024 --

DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm! Globe Newswire 4:00 PM

-- September 10, 2024 --

DYNE ALERT: Bragar Eagel & Squire, P.C. is Investigating Dyne Therapeutics, Inc. on Behalf of Dyne Stockholders and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM

-- September 9, 2024 --

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Dyne Therapeutics, Inc. (DYN) Business Wire 7:47 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN PRNewswire 5:15 PM

-- September 8, 2024 --

DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm! Business Wire 4:00 PM

-- September 6, 2024 --

DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm! PRNewswire 4:00 PM

-- September 5, 2024 --

(DYN) INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm! Globe Newswire 4:00 PM

-- September 4, 2024 --

DYN Investors Have Opportunity to Join Dyne Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Business Wire 5:19 PM

-- September 3, 2024 --

Dyne Therapeutics Announces Key Leadership Appointments Globe Newswire 6:31 AM
Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented Dystrophin Expression and Functional Improvement in Multiple Cohorts Globe Newswire 6:30 AM

-- August 29, 2024 --

Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference Globe Newswire 7:30 AM

-- August 12, 2024 --

Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights Globe Newswire 5:10 PM